1. Xanthoma usually has inflammation nearby.

2. Tuberosum haploid, Gp. Phureja and Gp.

3. Verruciform xanthoma of balanus is a rare condition.

4. Root and tubercle vegetables, other than tubers of Solanum tuberosum L.

5. So the method was a simple, facile, and effective non surgical therapy for xanthoma palpebrarum.

6. Objective To analyze the pathological features of xanthoma of bone and its differential diagnosis.

7. The histopathologic picture of the nodule over the coccyx showed numerous xanthoma cells and some fibroblastic proliferations.

8. Objective: To investigate the clinical biological profiles, pathological diagnosis and treatment of verruciform xanthoma of the oral mucosa.

9. Samples of coagulable protein, from tubers of 34 varieties ofSolanum tuberosum, were analysed for amino acids.

10. Pentland Crown.T. urticae were trapped on second-generationS. tuberosum × berthaultii with this type of hair.

11. Condyloma accuminatum has prominent koilocytosis in the upper epidermis that is not found in verruciform xanthoma.

12. 11 The histopathologic picture of the nodule over the coccyx showed numerous xanthoma cells and some fibroblastic proliferations.

13. 5 The histopathologic picture of the nodule over the coccyx showed numerous xanthoma cells and some fibroblastic proliferations.

14. Methods: The clinicopathological data of 6 cases with verruciform xanthoma of the oral mucosa were retrospectively analyzed, with follow-up.

15. Methods The clinicopathological features of bone xanthoma were studied, and the histochemical and immunohistochemical findings and follow-up results were analyzed in 5 cases.

16. In this paper, we present an 8-year-old normolipidemic male child with a parietal bone xanthoma proved using tissue diagnosis.

17. The major species grown worldwide is Solanum tuberosum (a tetraploid with 48 chromosomes), and modern varieties of this species are the most widely cultivated.

18. Xanthoma invasion of the bone is a very rare disease especially in normolipidemic children. Bone erosion can be found in patients with this disease.

19. Xanthelasma palpebrarum is the commonest Coetaneous presentation of xanthoma, which occurs over the eyelids, even with the absence of any other cutaneous or mucosal lesions

20. (Note: this article features Alliums that are grown from fall-planted bulbs rather than herbaceous Alliums such as Allium ‘Millenium’ and Allium tuberosum.)

21. The formation of ice in the petioles ofSolanum acaule andSolanum tuberosum has been studied by light microscopy and by continuous recordings of latent heat production.

22. On average, 73.7% of the chromosomes derived from S. acaule were detected as recombinants, suggesting that frequent homoeologous recombination occurred between S. acaule and S. tuberosum chromosomes.

23. High temperatures are known to reduce Anthocyanin accumulation in a number of diverse plant species. In potato (Solanum tuberosum L.), high temperature significantly reduces tuber Anthocyanin pigment content

24. The behaviour of the petiole ofBrassica oleracea was similar to that ofS. acaule, whilstBegonia rex, an extremely frost sensitive plant, froze similarly toS. tuberosum, but without any indication of a normal double cooling curve.

25. A Batata (Solanum tuberosum) é uma planta herbácea que pode atingir mais de 100 centímetros de altura e produz um tubérculo - a Batata - rico em amido

26. A positive correlation between amylose content of the parents and their progeny after selfing, crosses between sibs, and of the mentioned amylose-rich clones with 2 x or 4 xS. tuberosum could be ascertained.

27. Among the conditions treated are dry mouth syndrome, verruciform xanthoma, achlorhydria, mucous cysts, oral submucous fibrosis, oral nevi, cancer of the oral mucosa, maloplakia of the genito-urinary tract, vulvovaginitis, helicobacter plylori infection, duodenal ulcers, peptic ulcers, conditions affecting the uterus and appendicitis.

28. The Fagetum carpaticum submontanum (ass. Fagus silvatica-Dentaria bulbifera) with the geographical differentiation species Carex pilosa, Galium schultesii, Hacquetia epipactis, Isopyrum thalictroides, Dentaria glandulosa, Euphorbia amygdaloides, Symphytum tuberosum etc., which are characteristic to the southern part of the Carpathians.

29. concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a potato product (Solanum tuberosum L. line EH92-527-1) genetically modified for enhanced content of the amylopectin component of starch

30. Commission Decision of # March # concerning the placing on the market, in accordance with Directive #/#/EC of the European Parliament and of the Council, of a potato product (Solanum tuberosum L. line EH#-#-#) genetically modified for enhanced content of the amylopectin component of starch (notified under document C

31. In accordance with Article 13 of Directive 2001/18/EC, the Swedish authorities received from BASF Plant Science a notification (Reference C/SE/96/35-01) concerning the placing on the market of a potato ( Solanum tuberosum L. line EH92-527-1) genetically modified for enhanced content of the amylopectin component of starch.

32. Commission Decision 2010/135/EU of 2 March 2010 concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a potato product (Solanum tuberosum L. line EH92-527-1) genetically modified for enhanced content of the amylopectin of starch

33. The authorisation for the cultivation and industrial use of potato EH92-527-1 is provided by Commission Decision ...[ concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a potato product (Solanum tuberosum L. line EH92-527-1) genetically modified for enhanced content of the amylopectin component of starch]

34. 25 On 4 December 2006, the Regulatory Committee on the Release of Genetically Modified Organisms into the Environment, in accordance with Article 5(2) of Decision 1999/468, discussed a draft decision submitted by the Commission on the placing on the market, in accordance with Directive 2001/18, of a genetically modified potato (Solanum tuberosum L. line EH92-527-1) in order to obtain starch containing an increased amylopectin content.

35. Annuls Commission Decision 2010/135/EU of 2 March 2010 concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a potato product (Solanum tuberosum L. line EH92-527-1) genetically modified for enhanced content of the amylopectin component of starch, and Commission Decision 2010/136/EU of 2 March 2010 authorising the placing on the market of feed produced from the genetically modified potato EH92-527-1 (BPS-25271-9) and the adventitious or technically unavoidable presence of the potato in food and other feed products under Regulation (EC) No 1829/2003 of the European Parliament and of the Council;

36. Annulment of Commission Decision 2010/135/EU of 2 March 2010 concerning the placing on the market, in accordance with Directive 2001/18/EC of the European Parliament and of the Council, of a potato product (Solanum tuberosum L. line EH92-527-1) genetically modified for enhanced content of the amylopectin component of starch (OJ 2010 L 53, p. 11), and of Commission Decision 2010/136/EU of 2 March 2010 authorising the placing on the market of feed produced from the genetically modified potato EH92-527-1 (BPS-25271-9) and the adventitious or technically unavoidable presence of the potato in food and other feed products under Regulation (EC) No 1829/2003 of the European Parliament and of the Council (OJ 2010 L 53, p.